SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

JOHNSON PHARMACARE

BSE: 532154 29 Jun 2025
Services
₹ 0.86
JOHNSON PHARMACARE LIMITED specializes in Diversified Commercial Services within the Services sector.

JOHNSON PHARMACARE - Share Price & Details

Market Cap
₹49.5
High /Low
1.44 / 0.81
Stock P/E
NA
Book Value
₹1.02
Dividend Yield
0.0
ROCE
-0.71
ROE
₹-0.73
Face Value
1.0
PEG Ratio
NA
EVEBITDA
₹-122.0
Debt
0.61
CMP / FCF
-62.9
Debt to equity
₹0.01
NP Ann
-0.58
High price all time
21.0
Piotroski score
₹3.0
Graham Number
NA
No. Eq. Shares
55.0
Net CF
₹0.01
Net profit
-0.58
Price to book value
0.88
Interest Coverage
₹NA
Low price all time
0.11
Industry PE
23.1
Reserves
₹1.17
Free Cash Flow
₹-1.91

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Alna Trading & Exports Ltd.,NANANANA0
Oseaspre Consultants Ltd.,NANANANA0
JOHNSON PHARMACARE LIMITEDNANANANA49.5
ERP SOFT SYSTEMS LTD.NANANANA48.7221.0
GINI SILK MILLS LTD.NANANANA4726.1

Peer Comparison Chart


About JOHNSON PHARMACARE

JOHNSON PHARMACARE LIMITED, with Security Code 532154, is a leading player in the Diversified Commercial Services industry, categorized under the Services sector, offering Equity instruments.


Latest News

Vaxtex Cotfab reports standalone net profit of Rs 1.32 crore in the March 2025 quarter

(30 May 2025)
Sales reported at Rs 5.25 crore.
Read more →

Johnson Pharmacare reports standalone net loss of Rs 0.51 crore in the March 2025 quarter

(24 May 2025)
Reported sales nil. Net loss of Johnson Pharmacare reported to Rs 0.51 crore in the quarter ended March 2025. There were no net profit/loss reported during...
Read more →

A Pandemic Treaty Without Teeth Will Leave Africa and the World Exposed

(19 May 2025)
The world stands at a crossroads in global health governance. This week, the World Health Assembly will debate and possibly adopt the...
Read more →

Johnson & Johnson MedTech expands AI-led lung cancer care with Qure.ai

(11 May 2025)
This initiative is part of Project BreatheEZ, a broader strategic collaboration between Qure.ai and Johnson & Johnson MedTech. Read further.
Read more →

Nuvama Wealth Management consolidated net profit rises 42.97% in the December 2024 quarter

(01 Feb 2025)
Net profit of Nuvama Wealth Management rose 42.97% to Rs 252.10 crore in the quarter ended December 2024 as against Rs 176.33 crore during the previous quarter...
Read more →

LIC Housing Finance consolidated net profit rises 22.75% in the December 2024 quarter

(01 Feb 2025)
Net profit of LIC Housing Finance rose 22.75% to Rs 1434.84 crore in the quarter ended December 2024 as against Rs 1168.92 crore during the previous quarter...
Read more →